Skip to main content

ENANTIOS: Chiral Analysis Spin-off of ETH Zurich

ENANTIOS, an ETH Zurich spin-off, measures chirality in real time for pharma, food and agrochemicals. Technology, market and investment case.

ENANTIOS - Precision OpticsAixPoint Dirk Vandenhirtz, founder of AixPoint and AgTech advisor based in Aachen

Portfolio

Precision Optics

Chirality, measured. Raman Optical Activity instruments for pharma.

Stage
Seed
Country
CH
Founded
2020
Sector
Precision Optics

ENANTIOS is a Swiss precision-optics company building Raman Optical Activity (ROA) instruments that resolve a long-standing bottleneck in chiral analysis for pharmaceutical and biotech development.

After a CHF 1.8M seed in 2024 (Privilège Ventures, Zürcher Kantonalbank), the company shipped its first commercial instrument to Bar-Ilan University in 2025, achieved CE certification under MDR, and now counts two of the top-10 global pharma firms as customers.

AixPoint thesis

ENANTIOS is the textbook deep-tech bet: hard science, narrow market, defensible IP. AixPoint advises on patent portfolio architecture and the transition from measurement-as-a-service to product company.

enantios.com LinkedIn

How we help

patent portfolio analysis

FTO, claim architecture, filing roadmap, licensing risk, investor DD readiness.

Part of AgTech consulting · all portfolio companies